Industry-Academic Cooperation Foundation Yeungnam University Patent applications |
Patent application number | Title | Published |
20150069440 | LIGHT EMITTING DIODE AND METHOD OF MANUFACTURING THE SAME - Provided is a light emitting diode having a nanostructure capping pattern and a method of manufacturing the same. A light-emitting structure including a first semiconductor layer, a second semiconductor layer, and an active layer between the first and second semiconductor layers is provided. A nanostructure is provided on the light-emitting structure and a nanostructure capping pattern covering the nanostructure is provided. A refractive index of the nanostructure capping pattern is higher than that of air and lower than that of the nanostructure. | 03-12-2015 |
20140150865 | CONCENTRATING SOLAR CELL - The present invention relates to a solar cell capable of maximizing a concentrating area and cell efficiency by disposing a cell in a progress direction of light, that is, in a vertical direction to a concentrating direction. | 06-05-2014 |
20140140437 | METHOD OF CANCELLING INTER-SUBCARRIER INTERFERENCE IN DISTRIBUTED ANTENNA SYSTEM - Disclosed is a method of cancelling inter-subcarrier interferences in distributed antenna system. A method of cancelling interference performed in a transmitting station may include configuring a least one Alamouti pair by mapping subcarrier to each of input symbols, performing a 2N-point inverse fast Fourier transform (IFFT) on the at least one Alamouti pair, wherein the N is a natural number, and performing a frequency up converting on signals on which the 2N-point IFFT performed. Therefore, the inter-subcarrier interferences can be canceled efficiently. | 05-22-2014 |
20130337993 | METHOD FOR PREPARING POLYCRYSTALLINE ALUMINUM OXYNITRIDE HAVING ENHANCED TRANSPARENCY - Disclosed is a method for preparing polycrystalline aluminum oxynitride having enhanced transparency, and preparing polycrystalline aluminum oxynitride by sintering a powder mixture of Al | 12-19-2013 |
20130328508 | METHOD FOR CONTROLLING INTERIOR PERMANENT MAGNET SYNCHRONOUS MOTOR - Disclosed is a method for controlling a permanent magnet synchronous motor to maximize use of voltages of a battery by voltage phase control within weak magnetic flux area and to achieve compensation for a torque error through a torque compensator when driving the permanent magnet synchronous motor for hybrid vehicles. In particular, the method controls a permanent magnet synchronous motor so that voltage use can be maximized in a weak magnetic flux area by using voltage near maximum voltage through voltage phase control utilizing magnetic flux-based map data receiving a torque command and motor speed/batter output voltage as inputs and torque error can be compensated using a torque compensation filter when a motor constant is changed in the weak magnetic flux by a circumstance parameter, when the permanent magnet synchronous motor mounted in a hybrid vehicle and an electric vehicle is driven. | 12-12-2013 |
20130267558 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASES, CONTAINING CILOSTAZOL AS ACTIVE INGREDIENT - Provided is a pharmaceutical composition for the treatment and prevention of alcoholic liver diseases, including cilostazol as an active ingredient. Cilostazol inhibits expression levels of TNF-α and FAS (fatty acid synthase) gene in a concentration-dependent manner, and also significantly inhibits the activity of caspase-3. Accordingly, cilostazol shows superior effects for the treatment or prevention of alcoholic liver diseases, in particular, alcoholic hepatitis compared to pentoxifylline which is conventionally used as a therapeutic agent for the treatment for alcoholic hepatitis. Thus, cilostazol is suitable for use as a drug for the treatment or prevention of alcoholic hepatitis. | 10-10-2013 |
20130252879 | RAPAMYCIN FORMULATION USING RECOMBINANT HIGH-DENSITY LIPOPROTEIN INCLUDING APOLIPOPROTEIN A-I AND A MUTANT THEREOF - Provided is a rapamycin formulation using a recombinant high-density lipoprotein including apolipoprotein mutant, the rapamycin formulation in which solubility of rapamycin and medical use, such as aging suppression and arteriosclerosis suppression, are improved by using recombinant high-density lipoprotein including apolipoprotein A-I and its mutant V156K. | 09-26-2013 |
20130224902 | METHOD OF MANUFACTURING PHOTOVOLTAIC CELL - Provided is a method for manufacturing a photovoltaic cell in which a light absorption layer is formed by promoting chalcogenation. The method includes providing a microporous member, arranging an object on a first side of the microporous member, and arranging a chalcogen source on a second side of the microporous member opposite to the first side, heating the chalcogen source, transmitting a liquefied or evaporated portion of the heated chalcogen source through the microporous member, and exposing the object to the liquefied or evaporated portion of the heated chalcogen source that has passed through the microporous member | 08-29-2013 |
20130220219 | APPARATUS FOR MANUFACTURING PHOTOVOLTAIC CELL - Provided is an apparatus for manufacturing a photovoltaic cell in which a light absorption layer is formed by promoting chalcogenation. The apparatus includes a chamber, an object supporting element which is disposed inside the chamber and on which an object is mounted, and a microporous member which is disposed to cover the object supporting element, on which a chalcogen source is mounted, and which has micropores having such a size that the chalcogen source reaches the object through the micropores. | 08-29-2013 |
20130183456 | ANTI-MICROBIAL AND ANTI-STATIC SURFACE TREATMENT AGENT WITH QUATERNARY AMMONIUM SALT AS ACTIVE INGREDIENT AND METHOD FOR PREVENTING STATIC ELECTRICITY IN POLYMER FIBERS USING SAME - Provided are an anti-static and anti-microbial surface treatment agent including a quaternary ammonium salt compound as an active ingredient and a method of preventing a polymer fiber from developing static electricity by using the surface treatment agent. The quaternary ammonium salt compound has excellent anti-static and anti-microbial effects for the prevention or improvement of static electricity in a polymer fiber. Accordingly, the quaternary ammonium salt compound is suitable for use as a fabric softener, or an anti-static agent, and also, provides anti-microbial effects to a polymer fiber. | 07-18-2013 |
20130072466 | COMPOSITION CONTAINING PLACENTA EXTRACTS - Provided is a composition containing placenta extracts as active ingredients. Placenta extracts are natural substances extracted from placentas of livestock and show effects that can replace steroids and reduce adverse effects of steroids, so that placenta extracts have a wide range of applications including contraceptives, anti-osteoporosis drugs, anti-anemic drugs, therapeutic agents for wasting diseases of muscular atrophy, agents for treating sexual dysfunction, therapeutic agents for wounds, and adipocyte differentiation stimulating agents for improving meat quality of livestock, etc. | 03-21-2013 |
20130071107 | TRANSMITTER FOR WIRELESS OPTICAL COMMUNICATION SYSTEM USING LIGHT SOURCE - A transmission apparatus of a wireless light communication system using an illumination light source can maximize a rate of data transmission while maintaining a brightness adjusting function of the illumination light source. The transmission apparatus includes a dimming level input unit which receives a dimming level of the illumination light source as an input, a coder which codes original data and outputs the coded data, a dimming coder which checks the dimming level input to the dimming level input unit, generates a symbol-codeword table corresponding to the dimming level, and dimming-codes the data output from the coder, a line coder which converts the data diming-coded by the dimming coder into pulse signals. | 03-21-2013 |
20130018022 | PHARMACEUTICAL COMPOSITION INCLUDING A TESTIS EXTRACT AS AN ACTIVE INGREDIENT FOR TREATING AND PREVENTING ANEMIAAANM Choi; In-HoAACI Gyeongsan-siAACO KRAAGP Choi; In-Ho Gyeongsan-si KRAANM Lee; Dong-MokAACI DaeguAACO KRAAGP Lee; Dong-Mok Daegu KRAANM Lee; Eun-JuAACI DaeguAACO KRAAGP Lee; Eun-Ju Daegu KRAANM Lee; Ki-HoAACI SeoulAACO KRAAGP Lee; Ki-Ho Seoul KRAANM Cheon; Yong-PilAACI SeoulAACO KRAAGP Cheon; Yong-Pil Seoul KRAANM Chun; Tae-HoonAACI SeoulAACO KRAAGP Chun; Tae-Hoon Seoul KR - The present invention relates to a pharmaceutical composition including a testis extract serving as an active ingredient for treating and preventing anemia, in which since the testis extract induces proliferation of hematopoietic stem cell, an increase in the number of red blood cell, and an increase in the amount of hemoglobin, it is effectively used as a therapeutic agent for treating anemia related to red blood cell and hemoglobin in women of childbearing age, post-childbearing age, and during pregnancy, as well as in men. | 01-17-2013 |
20120154713 | LIQUID CRYSTAL DISPLAY - A liquid crystal display including: a liquid crystal panel including front and rear glass substrates, a plurality of liquid crystal sub-pixels for red, green, and blue respectively corresponding to three color, i.e., red, green, and blue, lights, and disposed between the front and rear glass substrates, and a color filter disposed between the plurality of liquid crystal sub-pixels and the front glass substrate; a backlight unit disposed behind the liquid crystal panel, and including a plurality of three color light suppliers spaced apart from each other in groups and supplying the three color lights; and a lenticular lens array disposed between the backlight unit and the liquid crystal panel, and inducing the three color lights emitted from the three color light suppliers to the liquid crystal sub-pixels and the color filter of the liquid crystal panel. According to the liquid crystal display, the lenticular lens array is attached to the liquid crystal panel so as to induce red, green, and blue lights respectively to red, green, and blue color filters inside the liquid crystal panel, thereby increasing light transmittance and decrease light loss. Accordingly, power consumption of the liquid crystal display is reduced, the liquid crystal display realizes high resolution, and manufacturing expenses of the liquid crystal display are reduced. | 06-21-2012 |
20120070014 | SAFE EARPHONE SYSTEM AND METHOD OF DRIVING THE SAME - Provided are a safety earphone system and a method of driving the same. The safe earphone system includes a microphone block that includes: a sound input terminal for receiving sound information from a sound system; a sound output terminal for receiving the sound information and transmitting the sound information to an earphone; a microphone unit for detecting an outside sound; and a controller for decreasing the sound information volume or blocking a connection between the sound output terminal and the sound input terminal if a level of the outside sound detected by the microphone unit exceeds a threshold value. Accordingly, an output state of the earphone is adjusted according to a level of the outside sound detected by a microphone module. In other words, a user may hear the outside sound while wearing the earphone since the sound information transmitted to the earphone is blocked if the level of the outside sound exceeds the threshold value. Thus, the user listens to important ambient sounds at a predetermined level or above while receiving the sound information, without having to remove the earphone. Also, the safety earphone system may be simply and easily applied to a conventional earphone or headset without having to largely change a structure of the conventional earphone or headset. | 03-22-2012 |
20100167907 | METHOD FOR MANUFACTURING TRANSPARENT POLYCRYSTALLINE ALUMINUM OXYNITRIDE - The present invention relates to a method of manufacturing a transparent polycrystalline aluminum oxynitride. Aluminum oxynitride manufactured by prior art methods has a great number of porosities therein and thus has low transparency. The present invention is directed to solving such a problem. In the method of manufacturing aluminum oxynitride of the present invention, a sintering additive added to a source powder includes less than 0.5 wt. % MgO. Further, the source powder is presintered at 1550° C. to 1750° C. so that a relative density becomes 95% or more and is then resintered at 1900° C. or more so that a relative density higher than that of presintering can be accomplished. According to the present invention, a cubic-phased polycrystalline aluminum oxynitride ceramic can be obtained, wherein porosities therein are nearly eliminated and its substantial transparency becomes 95% or more. | 07-01-2010 |
20090208986 | Method and kit for diagnosing acute myocardial infarction - Disclosed herein are method and kit for diagnosing acute myocardial infarction which is capable of predicting and diagnosing whether coronary artery disease is proceed to myocardial infarction or not by using an increase in triglyceride level in high density lipoprotein (HDL) or low density lipoprotein (LDL), a decrease in cholesterol level in HDL, increase of interleukin-6, CETP (cholesteryl ester transfer protein) and apo (apolipoprotein) C-III as a biomarker that are characteristic changes occurred only in sera of myocardial infarction patients among patients with coronary artery disease. | 08-20-2009 |